SCHEMBL20619655

SCHEMBL20619655

CNCC1CCCCCO1

nearest known ligand 0.46

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.42
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TP53 P04637 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2128830 0.98
SCHEMBL1191814 0.91
SCHEMBL1192014 0.91
SCHEMBL63653 0.91
SCHEMBL13410720 0.84
SCHEMBL21429861 0.77
SCHEMBL15368481 0.77 NPC1 (0.39) HPGDHTTKMT2ASMN1; SMN2
SCHEMBL11060437 0.77 HPGD (0.45) HPGDHTTKMT2AUSP2SMN1; SMN2
SCHEMBL9684500 0.77 KMT2A (0.42) HPGDHTTKMT2AMEN1USP2
SCHEMBL18226082 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019006295-A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-01-03 WO disclosed